Skip to Main Content

Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer

Conditions

Pancreas

Phase II

What is the purpose of this trial?

This phase II trial studies how well combination chemotherapy before and after surgery works in treating patients with localized pancreatic cancer. Drugs used in chemotherapy, such as leucovorin calcium, fluorouracil, irinotecan hydrochloride, and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving combination chemotherapy before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. Giving these treatments after surgery may kill any tumor cells that remain after surgery.

  • Trial with
    Yale Cancer Center
  • Start Date
    09/17/2017
  • End Date
    12/30/2019
Trial Image

For more information about this study, contact:

Christina Wiess

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    06/12/2020
  • Study HIC
    #1306012255